Evidence supporting the use of: Isoflavones (unspecified)
For the health condition: Osteoporosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Isoflavones, particularly those derived from soy, have been investigated for their potential role in supporting bone health and treating osteoporosis, primarily due to their phytoestrogenic properties. These compounds can mimic estrogenic activity in the body, which is relevant because estrogen deficiency after menopause is a major risk factor for osteoporosis. Epidemiological studies suggest that populations with higher dietary intake of isoflavones (e.g., in Asian countries) tend to have lower rates of osteoporotic fractures. Small randomized controlled trials and meta-analyses have shown that isoflavone supplementation can have modest positive effects on bone mineral density (BMD) in postmenopausal women, especially at the lumbar spine. However, the results across studies are inconsistent, with some failing to show significant benefits.

Mechanistically, isoflavones may reduce bone resorption and stimulate bone formation by binding to estrogen receptors in bone tissue. Despite these potential benefits, the overall quality of evidence is moderate to low, and clinical guidelines do not currently recommend isoflavones as a primary therapy for osteoporosis. Long-term safety data are also limited. Thus, while there is some scientific support for the use of isoflavones in osteoporosis, the evidence is not strong or conclusive, and it should not replace established osteoporosis treatments.

More about Isoflavones (unspecified)
More about Osteoporosis

Products containing Isoflavones (unspecified)

We currently have no products on Vitabase that contain this ingredient.